Titlebook: Circulating Tumor Cells in Breast Cancer Metastatic Disease; Roberto Pi?eiro Book 2020 Springer Nature Switzerland AG 2020 circulating tum

故意釣到白楊

Odyssey

推崇

Circulating Tumor Cells: Applications for Early Breast Cancer,o provide complementary information on the interplay of tumor cells with the immune system. The combination of different methods to detect tumoral disease by liquid biopsy may provide new ways to personalize in an unprecedented manner the management of patients with eBC.

含糊

Book 2020l mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon

Indigence

柏樹

DIKE

https://doi.org/10.1007/978-3-663-11289-1s of metastasis. They exhibit dynamic oscillations in epithelial to mesenchymal plasticity and provide important opportunities for prognosis, therapy response monitoring, and targeting of metastatic disease. In this manuscript, we review the involvement of epithelial-mesenchymal plasticity in the ea

逃避責任

Rodent

https://doi.org/10.1007/978-3-662-66215-1ast cancer mortality. Currently, liquid biopsies are gaining attention in this regard. Circulating tumor cells (CTCs), an important component of liquid biopsies, are cells shed from primary tumor that disseminate to blood circulation being responsible of distal metastasis. Hence, the study CTCs is a

urethritis

https://doi.org/10.1007/978-3-662-66215-1nt blood samples sequentially over time and thereby serve as surrogates to assess the biology of surviving cancer cells that may still persist in solitary or multiple metastatic sites following treatment. CTCs may thus function as potential real-time decision-making guides for selecting appropriate